| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 130 |
| 1 | ADALIMUMAB | 88 |
| 2 | METHOTREXATE | 87 |
| 3 | PREDNISONE | 63 |
| 4 | CYCLOPHOSPHAMIDE | 43 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 43 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 43 |
| 7 | CARBOPLATIN | 38 |
| 8 | ACETAMINOPHEN | 37 |
| 9 | LAMOTRIGINE | 36 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIRAPARIB TOSYLATE MONOHYDRATE AND ABIRATERONE ACETATE | 1 | 0.0161 |
| 1 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 2 | CLEMASTINE FUMARATE | 9 | 0.0065 |
| 3 | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | 1 | 0.0061 |
| 4 | ZONGERTINIB | 1 | 0.0060 |
| 5 | CASTOR OIL | 1 | 0.0052 |
| 6 | TETRAHYDROZOLINE HYDROCHLORIDE | 1 | 0.0034 |
| 7 | POTASSIUM IODIDE | 4 | 0.0027 |
| 8 | LUMASIRAN | 1 | 0.0026 |
| 9 | FOSNETUPITANT AND PALONOSETRON | 3 | 0.0025 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 127 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 96 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 94 |
| 3 | Platinum-based Drug [EPC] | 78 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 71 |
| 5 | Alkylating Drug [EPC] | 65 |
| 6 | Kinase Inhibitor [EPC] | 49 |
| 7 | Microtubule Inhibitor [EPC] | 49 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 45 |
| 9 | Anti-epileptic Agent [EPC] | 44 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 1 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 4 | 0.0012 |
| 3 | Paramagnetic Contrast Agent [EPC] | 4 | 0.0009 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 11 | 0.0009 |
| 5 | Anthracycline Topoisomerase Inhibitor [EPC] | 2 | 0.0008 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 6 | 0.0007 |
| 7 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 4 | 0.0005 |
| 8 | Echinocandin Antifungal [EPC] | 4 | 0.0005 |
| 9 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |